EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.


Gumus M. , GEREDELI C., UCAR M., KAYA S., DEMIR H., UNAL O. U. , et al.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35